Report of Foreign Issuer (6-k)
October 28 2016 - 9:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
October 28, 2016
PROQR THERAPEUTICS N.V.
Zernikedreef 9
2333 CK
Leiden
The Netherlands
Tel: +31 88 166 7000
(Address, Including ZIP Code, and Telephone Number,
Including Area Code, of Registrants Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Other Events
On October 27, 2016, ProQR Therapeutics N.V. (the Company) held an investor presentation, which was accompanied by a slide presentation. A
copy of the slide presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information in Exhibit 99.1 (which is
furnished only) of this Report of Foreign Private Issuer on Form 6-K shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject
to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such filing.
EXHIBITS
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Slide Presentation, dated October 27, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
PROQR THERAPEUTICS N.V.
|
|
|
|
|
Date: October 28, 2016
|
|
|
|
By:
|
|
/s/ Smital Shah
|
|
|
|
|
|
|
|
|
Smital Shah
Chief Financial
Officer
|
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Mar 2024 to Apr 2024
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Apr 2023 to Apr 2024